Jordan M. Greenberg
Research Subjects
Jordan M. Greenberg has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Alicia Henn
Biospherix , Lacona, New York, USA
1 shared publicationAnthony Atala
Wake Forest Institute for Regenerative Medicine , Winston-Salem, North Carolina, USA
1 shared publicationCarlos M. Carballosa
Department of Biomedical Engineering, College of Engineering, University of Miami, Coral Gables, Florida, USA
1 shared publicationCat Lutz
Jackson Labs , Mount Desert Island, Maine, USA
1 shared publication- Herman S. Cheung
Department of Biomedical Engineering, College of Engineering, University of Miami, Coral Gables, Florida, USA
1 shared publication Jeff Krukin
Orbital Transports , Chicago, Illinois, USA
1 shared publication
Latest Publications
- Open Access
- 27 August 2020
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 10 (1) , 5-13
Regen med therapeutic opportunities for fighting COVID-19
This perspective from a Regenerative Medicine Manufacturing Society working group highlights regenerative medicine therapeutic opportunities for fighting COVID-19. This article addresses why SARS-CoV-2 is so different from other viruses and how regenerative medicine is poised to deliver new therapeutic opportunities to battle COVID-19. We describe animal models that depict the mechanism of action for COVID-19 and that may help identify new treatments. Additionally, organoid platforms that can recapitulate some of the physiological properties of human organ systems, such as the lungs and the heart, are discussed as potential platforms that may prove useful in rapidly screening new drugs and identifying at-risk patients. This article critically evaluates some of the promising regenerative medicine-based therapies for treating COVID-19 and presents some of the collective technologies and resources that the scientific community currently has available to confront this pandemic.
- 27 August 2020
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 10 (1) , 5-13
Open AccessRegen med therapeutic opportunities for fighting COVID-19
This perspective from a Regenerative Medicine Manufacturing Society working group highlights regenerative medicine therapeutic opportunities for fighting COVID-19. This article addresses why SARS-CoV-2 is so different from other viruses and how regenerative medicine is poised to deliver new therapeutic opportunities to battle COVID-19. We describe animal models that depict the mechanism of action for COVID-19 and that may help identify new treatments. Additionally, organoid platforms that can recapitulate some of the physiological properties of human organ systems, such as the lungs and the heart, are discussed as potential platforms that may prove useful in rapidly screening new drugs and identifying at-risk patients. This article critically evaluates some of the promising regenerative medicine-based therapies for treating COVID-19 and presents some of the collective technologies and resources that the scientific community currently has available to confront this pandemic.
- Open Access
- 11 July 2017
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 6 (9) , 1815-1821
Concise Review: The Deleterious Effects of Cigarette Smoking and Nicotine Usage and Mesenchymal Stem Cell Function and Implications for Cell-Based Therapies
Stem cell sources for cell-based therapeutics are often screened for infectious agents and genetic diseases prior to implantation; however, there are other risk factors that are often overlooked which may ultimately lead to less efficacious clinical outcomes. One such risk factor is exposure of mesenchymal stem cells (MSCs) to cigarette smoke or nicotine. Recent data have shown that exposure to cigarette smoke or nicotine leads to decreased regenerative potential, namely decreased proliferation, decreased migration, and decreased differentiation potential of exposed MSCs. This review provides a brief introduction into MSCs and their respective niches and a summary regarding the interactions of cigarettes and nicotine with MSCs populations. Specifically, the effects of cigarette smoke and nicotine on the regenerative potential of MSCs (i.e., proliferation, migration, and differentiation) will be covered with an emphasis on considerations for the development of future cell based clinical trials and therapies. Stem Cells Translational Medicine 2017
- 11 July 2017
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 6 (9) , 1815-1821
Open AccessConcise Review: The Deleterious Effects of Cigarette Smoking and Nicotine Usage and Mesenchymal Stem Cell Function and Implications for Cell-Based Therapies
Stem cell sources for cell-based therapeutics are often screened for infectious agents and genetic diseases prior to implantation; however, there are other risk factors that are often overlooked which may ultimately lead to less efficacious clinical outcomes. One such risk factor is exposure of mesenchymal stem cells (MSCs) to cigarette smoke or nicotine. Recent data have shown that exposure to cigarette smoke or nicotine leads to decreased regenerative potential, namely decreased proliferation, decreased migration, and decreased differentiation potential of exposed MSCs. This review provides a brief introduction into MSCs and their respective niches and a summary regarding the interactions of cigarettes and nicotine with MSCs populations. Specifically, the effects of cigarette smoke and nicotine on the regenerative potential of MSCs (i.e., proliferation, migration, and differentiation) will be covered with an emphasis on considerations for the development of future cell based clinical trials and therapies. Stem Cells Translational Medicine 2017